首页> 外文期刊>Asian journal of research in chemistry >Development and Validation of RP-HPLC Method for Simultaneous Estimation of Naproxen and Esomeprazole in Pharmaceutical Dosage Form
【24h】

Development and Validation of RP-HPLC Method for Simultaneous Estimation of Naproxen and Esomeprazole in Pharmaceutical Dosage Form

机译:RP-HPLC法同时测定萘普生和埃索美拉唑的药物剂型开发与验证

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of the study was to develop a simple, accurate, precise RP-HPLC method for the determination of Esomeprazole and Naproxen using mobile phase (A mixture of Acetonitrile and Methanol in the ratio of 60:40 was considered to be the optimal composition of solvent) as the solvent. The proposed method was involves the measurement of retention time at selected analytical wavelength 260.0 nm was selected as the analytical wavelength. The retention time of Esomeprazole and Naproxen was found to be 3.425 and 4.352, The linearity of the proposed method was in the range of r = 0.9999 for Esomeprazole and r = 0.9999 for Naproxen. The method was statistically validated for its linearity, accuracy and precision of the formulation.
机译:该研究的目的是开发一种简单,准确,精确的RP-HPLC方法,以流动相测定埃索美拉唑和萘普生(乙腈和甲醇的比例为60:40的混合物被认为是最佳的组成)。溶剂)作为溶剂。所提出的方法涉及在选择的分析波长260.0 nm处选择保留时间的测量作为分析波长。发现埃索美拉唑和萘普生的保留时间分别为3.425和4.352。所提出方法的线性对于埃索美拉唑为r = 0.9999,对于萘普生为r = 0.9999。该方法的线性,准确性和精密度在统计学上得到验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号